136 related articles for article (PubMed ID: 3246565)
1. Ocular distribution studies of the topical carbonic anhydrase inhibitors L-643,799 and L-650,719 and related alkyl prodrugs.
Grove J; Gautheron P; Plazonnet B; Sugrue MF
J Ocul Pharmacol; 1988; 4(4):279-90. PubMed ID: 3246565
[TBL] [Abstract][Full Text] [Related]
2. Biopharmaceutical explanation for the topical activity of 6-hydroxyethoxy-2-benzothiazolesulfonamide in the rabbit eye.
Lee DY; Schoenwald RD; Barfknecht CF
J Ocul Pharmacol; 1992; 8(3):247-65. PubMed ID: 1453087
[TBL] [Abstract][Full Text] [Related]
3. L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals.
Sugrue MF; Gautheron P; Mallorga P; Nolan TE; Graham SL; Schwam H; Shepard KL; Smith RL
Br J Pharmacol; 1990 Jan; 99(1):59-64. PubMed ID: 2110013
[TBL] [Abstract][Full Text] [Related]
4. Effect of pH on the ocular distribution of a topical carbonic anhydrase inhibitor.
Conroy CW; Maren TH
Exp Eye Res; 1995 Aug; 61(2):213-22. PubMed ID: 7556485
[TBL] [Abstract][Full Text] [Related]
5. Ocular disposition of aminozolamide in the rabbit eye.
Putnam ML; Schoenwald RD; Duffel MW; Barfknecht CF; Segarra TM; Campbell DA
Invest Ophthalmol Vis Sci; 1987 Aug; 28(8):1373-82. PubMed ID: 3610554
[TBL] [Abstract][Full Text] [Related]
6. Penetration into the anterior chamber via the conjunctival/scleral pathway.
Schoenwald RD; Deshpande GS; Rethwisch DG; Barfknecht CF
J Ocul Pharmacol Ther; 1997 Feb; 13(1):41-59. PubMed ID: 9029439
[TBL] [Abstract][Full Text] [Related]
7. A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion.
Brechue WF; Maren TH
Exp Eye Res; 1993 Jul; 57(1):67-78. PubMed ID: 8405174
[TBL] [Abstract][Full Text] [Related]
8. Ocular penetration and hypotensive activity of the topically applied carbonic anhydrase inhibitor L-645,151.
Bar-Ilan A; Pessah NI; Maren TH
J Ocul Pharmacol; 1986; 2(2):109-20. PubMed ID: 3503100
[TBL] [Abstract][Full Text] [Related]
9. Ocular disposition of topically applied histamine, cimetidine, and pyrilamine in the albino rabbit.
Hui HW; Zeleznick L; Robinson JR
Curr Eye Res; 1984 Feb; 3(2):321-30. PubMed ID: 6705556
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics of dorzolamide.
Martens-Lobenhoffer J; Banditt P
Clin Pharmacokinet; 2002; 41(3):197-205. PubMed ID: 11929320
[TBL] [Abstract][Full Text] [Related]
11. Intraocular penetration of topical clindamycin in rabbits.
Mercer KB; DeOlden JE; Leopoid IH
Arch Ophthalmol; 1978 May; 96(5):880-4. PubMed ID: 655926
[TBL] [Abstract][Full Text] [Related]
12. MK-927: a topically active ocular hypotensive carbonic anhydrase inhibitor.
Sugrue MF; Gautheron P; Grove J; Mallorga P; Viader MP; Schwam H; Baldwin JJ; Christy ME; Ponticello GS
J Ocul Pharmacol; 1990; 6(1):9-22. PubMed ID: 2362161
[TBL] [Abstract][Full Text] [Related]
13. Characterization of arylamine acetyltransferase in the rabbit eye.
Campbell DA; Schoenwald RD; Duffel MW; Barfknecht CF
Invest Ophthalmol Vis Sci; 1991 Jul; 32(8):2190-200. PubMed ID: 2071333
[TBL] [Abstract][Full Text] [Related]
14. Ocular pharmacokinetics of dorzolamide and brinzolamide after single and multiple topical dosing: implications for effects on ocular blood flow.
Kadam RS; Jadhav G; Ogidigben M; Kompella UB
Drug Metab Dispos; 2011 Sep; 39(9):1529-37. PubMed ID: 21673129
[TBL] [Abstract][Full Text] [Related]
15. Corneal and scleral penetration studies of 6-hydroxyethoxy-2-benzothiazole sulfonamide: a topical carbonic anhydrase inhibitor.
Kao KD; Lu DW; Chiang CH; Huang HS
J Ocul Pharmacol; 1990; 6(4):313-20. PubMed ID: 2097315
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, acid-base balance and intraocular pressure effects of ethyloxaloylazolamide--a novel topically active carbonic anhydrase inhibitor.
Sharir M; Pierce WM; Chen D; Zimmerman TJ
Exp Eye Res; 1994 Jan; 58(1):107-16. PubMed ID: 8157096
[TBL] [Abstract][Full Text] [Related]
17. The ocular distribution of methazolamide after corneal and scleral administration: the effect of ionization state.
Conroy CW; Maren TH
J Ocul Pharmacol Ther; 1998 Dec; 14(6):565-73. PubMed ID: 9867339
[TBL] [Abstract][Full Text] [Related]
18. pH and drug ionization affects ocular pressure lowering of topical carbonic anhydrase inhibitors.
Brechue WF; Maren TH
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2581-7. PubMed ID: 8325759
[TBL] [Abstract][Full Text] [Related]
19. The ocular pharmacokinetics of eicosanoids and their derivatives. 1. Comparison of ocular eicosanoid penetration and distribution following the topical application of PGF2 alpha, PGF2 alpha-1-methyl ester, and PGF2 alpha-1-isopropyl ester.
Bito LZ; Baroody RA
Exp Eye Res; 1987 Feb; 44(2):217-26. PubMed ID: 3472899
[TBL] [Abstract][Full Text] [Related]
20. Aminozolamide suspension: the role of the vehicle in a topical carbonic anhydrase inhibitor.
Lewis RA; Schoenwald RD; Barfknecht CF
J Ocul Pharmacol; 1988; 4(3):215-9. PubMed ID: 3198983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
